Key Points
- Saiyed Atiq Raza, an Arteris director, sold 90,000 shares on May 1 at an average price of $28.71 for $2.5839M under a pre-arranged Rule 10b5-1 plan, leaving him with 210,000 shares (a 30% reduction).
- The sale is part of multiple large insider disposals from Feb–Apr totaling hundreds of thousands of shares, occurring as AIP trades near its 1‑year high (~$29.50) and carries a consensus analyst rating of "Hold" with an average target of $20.17.
Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 90,000 shares of Arteris stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $28.71, for a total transaction of $2,583,900.00. Following the completion of the sale, the director owned 210,000 shares in the company, valued at approximately $6,029,100. This trade represents a 30.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Saiyed Atiq Raza also recently made the following trade(s):
- On Monday, April 20th, Saiyed Atiq Raza sold 17,060 shares of Arteris stock. The stock was sold at an average price of $22.16, for a total transaction of $378,049.60.
- On Friday, April 17th, Saiyed Atiq Raza sold 72,940 shares of Arteris stock. The shares were sold at an average price of $22.16, for a total transaction of $1,616,350.40.
- On Wednesday, March 4th, Saiyed Atiq Raza sold 3,690 shares of Arteris stock. The stock was sold at an average price of $17.02, for a total value of $62,803.80.
- On Monday, March 2nd, Saiyed Atiq Raza sold 106,031 shares of Arteris stock. The stock was sold at an average price of $17.21, for a total value of $1,824,793.51.
- On Friday, February 27th, Saiyed Atiq Raza sold 11,762 shares of Arteris stock. The shares were sold at an average price of $17.01, for a total value of $200,071.62.
- On Thursday, February 26th, Saiyed Atiq Raza sold 73,610 shares of Arteris stock. The shares were sold at an average price of $17.14, for a total value of $1,261,675.40.
- On Wednesday, February 25th, Saiyed Atiq Raza sold 4,907 shares of Arteris stock. The shares were sold at an average price of $17.00, for a total value of $83,419.00.
Arteris Price Performance
Shares of NASDAQ:AIP opened at $28.85 on Tuesday. Arteris, Inc. has a 1 year low of $6.64 and a 1 year high of $29.50. The firm has a market capitalization of $1.33 billion, a PE ratio of -35.18 and a beta of 1.93. The business's 50 day moving average price is $18.51 and its 200-day moving average price is $16.40.
Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings data on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. The firm had revenue of $20.14 million during the quarter, compared to analyst estimates of $18.55 million. As a group, analysts expect that Arteris, Inc. will post -0.68 earnings per share for the current year.
Wall Street Analysts Forecast Growth
AIP has been the topic of several research reports. Wall Street Zen downgraded shares of Arteris from a "buy" rating to a "hold" rating in a research note on Saturday. Northland Securities set a $24.00 price objective on shares of Arteris in a research note on Friday, February 13th. Rosenblatt Securities reissued a "buy" rating and issued a $20.00 target price on shares of Arteris in a research note on Friday, February 13th. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Arteris in a report on Monday, April 20th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $20.17.
Get Our Latest Report on AIP
Institutional Investors Weigh In On Arteris
A number of hedge funds have recently modified their holdings of the company. Raymond James Financial Inc. acquired a new stake in Arteris during the second quarter worth about $32,000. BNP Paribas Financial Markets boosted its holdings in Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company's stock valued at $61,000 after purchasing an additional 2,595 shares during the last quarter. Strs Ohio purchased a new stake in shares of Arteris in the 1st quarter valued at approximately $104,000. Penn Capital Management Company LLC purchased a new stake in shares of Arteris in the 3rd quarter valued at approximately $109,000. Finally, Susquehanna Fundamental Investments LLC acquired a new stake in shares of Arteris during the 3rd quarter worth approximately $113,000. Hedge funds and other institutional investors own 64.36% of the company's stock.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
